Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/67388
Título: | Detection of the Prostate Cancer Biomarker PCA3 with Electrochemical and Impedance-Based Biosensors |
Autor(es): | Soares, Juliana Coatrini Soares, Andrey Coatrini Rodrigues, Valquiria Cruz Melendez, Matias Eliseo Santos, Alexandre Cesar Faria, Eliney Ferreira Reis, R. M. Carvalho, Andre Lopes Oliveira, Osvaldo N. |
Palavras-chave: | Antigens, Neoplasm Biomarkers, Tumor Cell Line, Tumor DNA, Single-Stranded Dielectric Spectroscopy Humans Male Nanotubes, Carbon Prostate Prostate-Specific Antigen Prostatic Neoplasms RNA, Long Noncoding Biosensing Techniques Biosensors prostate cancer PCA3 Impedance spectroscopy EIS DNA biosensors prostate cancer |
Data: | 18-Dez-2019 |
Editora: | American Chemical Society |
Revista: | ACS Applied Materials & Interfaces |
Citação: | Soares, J. C., Soares, A. C., Rodrigues, V. C., Melendez, M. E., et. al.(2019). Detection of the Prostate Cancer Biomarker PCA3 with Electrochemical and Impedance-Based Biosensors. ACS Applied Materials & Interfaces, 11(50), 46645-46650 |
Resumo(s): | Diagnosis of prostate cancer via PCA3 biomarker detection is promising to be much more efficient than with the prostatic specific antigens currently used. In this study, we present the first electrochemical and impedance-based biosensors that are capable of detecting PCA3 down to 0.128 nmol/L. The biosensors were made with a layer of PCA3-complementary single-stranded DNA (ssDNA) probe, immobilized on a layer-by-layer (LbL) film of chitosan (CHT) and carbon nanotubes (MWCNT). They are highly selective to PCA3, which was confirmed in impedance measurements and with polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS). Using information visualization methods, we could also distinguish between cell lines expressing the endogenous PCA3 long noncoding RNA (lncRNA) from cells that did not contain detectable levels of this biomarker. Since the methods involved in fabrication the biosensors are potentially low cost, one may hope to deploy PCA3 tests in any laboratory of clinical analyses and even for point-of-care diagnostics. |
Tipo: | Artigo |
URI: | https://hdl.handle.net/1822/67388 |
e-ISBN: | 1944-8252 |
DOI: | 10.1021/acsami.9b19180 |
ISSN: | 1944-8244 |
Versão da editora: | https://pubs.acs.org/doi/abs/10.1021/acsami.9b19180 |
Arbitragem científica: | yes |
Acesso: | Acesso restrito autor |
Aparece nas coleções: | ICVS - Artigos em revistas internacionais / Papers in international journals |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
soares2019.pdf Acesso restrito! | 343,85 kB | Adobe PDF | Ver/Abrir |